CCR5 and acute respiratory distress syndrome: Outside of its efficacy in blocking CCR5-tropic HIV-1 entry, CCR5 antagonism could be useful in preventing the ‘second wave’ of inflammatory mediators in SARS-CoV-2 patients that are responsible for the acute respiratory distress syndrome (ARDS).